DK0978284T3 - Anvendelse af 15-keto-prostaglandin-E-forbindelser som endothelinantagonister - Google Patents

Anvendelse af 15-keto-prostaglandin-E-forbindelser som endothelinantagonister

Info

Publication number
DK0978284T3
DK0978284T3 DK98953058T DK98953058T DK0978284T3 DK 0978284 T3 DK0978284 T3 DK 0978284T3 DK 98953058 T DK98953058 T DK 98953058T DK 98953058 T DK98953058 T DK 98953058T DK 0978284 T3 DK0978284 T3 DK 0978284T3
Authority
DK
Denmark
Prior art keywords
keto
prostaglandin
compounds
endothelin antagonists
endothelin
Prior art date
Application number
DK98953058T
Other languages
Danish (da)
English (en)
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Application granted granted Critical
Publication of DK0978284T3 publication Critical patent/DK0978284T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK98953058T 1997-11-28 1998-11-16 Anvendelse af 15-keto-prostaglandin-E-forbindelser som endothelinantagonister DK0978284T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP32783297 1997-11-28
PCT/JP1998/005143 WO1999027934A1 (fr) 1997-11-28 1998-11-16 Antagoniste d'endotheline

Publications (1)

Publication Number Publication Date
DK0978284T3 true DK0978284T3 (da) 2008-10-27

Family

ID=18203488

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98953058T DK0978284T3 (da) 1997-11-28 1998-11-16 Anvendelse af 15-keto-prostaglandin-E-forbindelser som endothelinantagonister

Country Status (17)

Country Link
US (1) US6197821B1 (ja)
EP (1) EP0978284B1 (ja)
JP (1) JP4319256B2 (ja)
KR (1) KR100648868B1 (ja)
CN (1) CN1206997C (ja)
AT (1) ATE401894T1 (ja)
AU (1) AU739343B2 (ja)
CA (1) CA2279267C (ja)
DE (1) DE69839767D1 (ja)
DK (1) DK0978284T3 (ja)
ES (1) ES2310013T3 (ja)
HK (1) HK1025521A1 (ja)
NO (1) NO328460B1 (ja)
NZ (1) NZ336960A (ja)
PT (1) PT978284E (ja)
TW (1) TW592701B (ja)
WO (1) WO1999027934A1 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002330747B2 (en) * 2001-08-31 2007-07-19 Sucampo Ag Prostaglandin analogs as chloride channel opener
AR037524A1 (es) 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
US7732487B2 (en) 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
TWI336254B (en) * 2002-12-27 2011-01-21 Sucampo Ag Pharmaceutical composition for treating abdominal discomfort
US20040225014A1 (en) * 2003-02-14 2004-11-11 Sucampo Ag Method for treating ocular hypertension and glaucoma
TWI384988B (zh) * 2005-01-27 2013-02-11 Sucampo Ag 處理中樞神經系統失常用之組成物
JP5213448B2 (ja) * 2005-03-04 2013-06-19 スキャンポ・アーゲー 末梢血管疾患の処置のための方法および組成物
CN103755737A (zh) * 2006-02-07 2014-04-30 株式会社·R-技术上野 用于制备前列腺素衍生物的方法
MX2008011148A (es) * 2006-02-28 2008-09-08 Sucampo Ag Metodo y composicion para tratar enfermedad pulmonar obstructiva cronica.
SG174050A1 (en) * 2006-04-13 2011-09-29 Actelion Pharmaceuticals Ltd Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis
EP2114411A2 (en) * 2007-02-27 2009-11-11 Sucampo AG Composition and method for protecting mitochondria
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
CN102050808B (zh) * 2009-11-02 2014-03-12 上海天伟生物制药有限公司 一种前列腺素中间体的制备方法
US20120309990A1 (en) * 2009-12-18 2012-12-06 Apotex Pharmachem Inc. Processes for the Purification of Lubiprostone
CN104557845B (zh) * 2015-01-13 2020-12-22 齐鲁制药有限公司 一种鲁比前列酮化合物的制备方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3853951A (en) 1971-07-14 1974-12-10 American Cyanamid Co Preparation of 9-oxo-13-trans-prostenoic acid esters by alanate addition to cyclopentenone
US4018811A (en) 1972-02-11 1977-04-19 American Cyanamid Company 3-Alkyl-2-(6-carboxyhexyl)cyclopentanones and esters and salts thereof
US3981868A (en) 1973-05-31 1976-09-21 American Cyanamid Company Derivatives of 9-oxo-13-trans-prostenoic acid amides
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
US5362751A (en) 1988-05-11 1994-11-08 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Tracheobronchodilator using 16-substituted PGEs
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
EP0343904B1 (en) 1988-05-23 1993-04-28 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Hypersphyxia causing composition
JPH0232031A (ja) * 1988-07-22 1990-02-01 Nippon Steel Chem Co Ltd イソプロピル化ｐ‐ターフェニル類の製造法
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
CA2030344C (en) * 1989-11-22 2000-04-18 Ryuji Ueno Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
CA2030346C (en) * 1989-11-22 2000-04-11 Ryuji Ueno Treatment of cardiac dysfunction with 15-keto-prostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
CA2039420C (en) 1990-04-04 1996-12-10 Ryuji Ueno Treatment of cataract with 15-keto-prostaglandin compounds
ATE174221T1 (de) * 1990-05-01 1998-12-15 R Tech Ueno Ltd Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
EP0503887B1 (en) * 1991-03-14 1996-08-28 R-Tech Ueno Ltd. Promotion of wound-healing with 15-keto-prostaglandin compounds
WO1997047595A1 (fr) 1996-06-10 1997-12-18 R-Tech Ueno, Ltd. Antagoniste de l'endotheline
JPH107574A (ja) 1996-06-17 1998-01-13 R Tec Ueno:Kk エンドセリン拮抗剤

Also Published As

Publication number Publication date
PT978284E (pt) 2008-10-07
HK1025521A1 (en) 2000-11-17
WO1999027934A1 (fr) 1999-06-10
CN1206997C (zh) 2005-06-22
EP0978284A4 (en) 2001-07-18
NO993647D0 (no) 1999-07-27
CA2279267A1 (en) 1999-06-10
NZ336960A (en) 2001-02-23
US6197821B1 (en) 2001-03-06
ES2310013T3 (es) 2008-12-16
DE69839767D1 (de) 2008-09-04
EP0978284A1 (en) 2000-02-09
CN1251040A (zh) 2000-04-19
KR20000070508A (ko) 2000-11-25
AU1053799A (en) 1999-06-16
ATE401894T1 (de) 2008-08-15
TW592701B (en) 2004-06-21
NO993647L (no) 1999-09-27
NO328460B1 (no) 2010-02-22
EP0978284B1 (en) 2008-07-23
JP4319256B2 (ja) 2009-08-26
KR100648868B1 (ko) 2006-11-24
CA2279267C (en) 2010-01-12
AU739343B2 (en) 2001-10-11

Similar Documents

Publication Publication Date Title
DK0978284T3 (da) Anvendelse af 15-keto-prostaglandin-E-forbindelser som endothelinantagonister
EA200000381A1 (ru) Препарат 2-метил-тиено-бензодиазепина
ATE497385T1 (de) Neue phenylalanin-derivate
AU2003211560A1 (en) Novel phenylalanine derivative
FI903331A0 (fi) Substituerade kinazolinoner, vilka aer anvaendbara som angiotensin-ii-antagonister.
DE69714698T2 (de) Endothelin-antagonisten
LV12639B (lv) Bifenilsulfonamidi ka duali angiotenzina un endotelina receptoru antagonisti
PT911333E (pt) Derivados de pirazolo¬4,3-d|pirimidina e composicoes farmaceuticas que os contenham
CO4940465A1 (es) Sal mesilato trihidrato de 5-(2-(4-(1,2-benzoisotiazol-3- il)-1-piperazinil)etil)-6-cloro-1,3-dihidro-2h-indol-2-ona
ES2179881T3 (es) Antagonistas de endotelina.
TR199501132A2 (tr) Nörokinin karsitlari (antagonistleri).
BR9804027A (pt) Novos beta-ceto ésteres
DE69935873D1 (de) 2-Methyl-thieno-benzodiazepin Formulierung
DE69938258D1 (de) 4,5-pyrazinoxindole als proteinkinasehemmer
ID23053A (id) Karboksamida yang digunakan sebagai agonis 5-ht <if>
DE60224221D1 (de) Aminotetralinderivate, antagonisten von muscarinrezeptoren
EA200401137A1 (ru) Фармацевтическая композиция, содержащая ингибитор pde4 или pde3/4 и антагонист гистаминового рецептора
UY26574A1 (es) " procedimiento para la separación enzimática de racematos de derivados de aminometil-aril-ciclohexanol".
HN1999000027A (es) Nuevas composiciones herbicidas
EA200500878A1 (ru) Кальцилитические соединения
NO20000518L (no) 2-acylaminopropanaminer som takykininreseptorantagonister
NO20002575D0 (no) Substituerte oksimer som neurokininantagonister
DE9413297U1 (de) Bohrerschaftverlängerung
DE50310743D1 (de) Wässrige formulierungen von (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4- trifluorbutan-1-sulfonat
ECSP972052A (es) Quinoxalinadionas